Conexiant’s news site is now MDSpire News. Learn more
Advertisement
How Genomics Is Personalizing Drug Discovery
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention